Sexually Transmitted Diseases and the Increased Risk for HIV Transmission: Implications for Cost-Effectiveness Analyses of Sexually Transmitted Disease Prevention Interventions
- 1 May 2000
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 24 (1) , 48-56
- https://doi.org/10.1097/00042560-200005010-00009
Abstract
No abstract availableThis publication has 71 references indexed in Scilit:
- From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infectionSexually Transmitted Infections, 1999
- Sexually transmitted diseases enhance HIV transmission: no longer a hypothesisThe Lancet, 1998
- Screening Women for Chlamydia trachomatis in Family Planning ClinicsSexually Transmitted Diseases, 1998
- Partner Notification for SyphilisSexually Transmitted Diseases, 1997
- Partner Notification to Prevent Pelvic Inflammatory Disease in WomenSexually Transmitted Diseases, 1997
- The Cost Effectiveness of Azithromycin for Chlamydia trachomatis Infections in WomenSexually Transmitted Diseases, 1995
- Cost‐effectiveness of antenatal screening for syphilisHealth Care for Women International, 1995
- Epidemiological SynergySexually Transmitted Diseases, 1992
- Emergency department screening for syphilis in patients with other suspected sexually transmitted diseasesAnnals of Emergency Medicine, 1991
- Should women be tested for gonococcal infection of the cervix during routine gynecologic visits? An economic appraisalThe American Journal of Medicine, 1989